PT Kalbe Farma Tbk 2013 AR2
The report highlights PT Kalbe Farma Tbk.'s financial and operational performance for the fiscal year 2013, showcasing a 17.3% sales growth and a 10.7% increase in net profit. Key achievements include the completion of a new oncology production facility, the expansion of the Kalbe e-Store to 35 cities, and the licensing of the first stem cell laboratory in Indonesia. In terms of sustainability, the company engaged over 4,200 employee volunteers in corporate social responsibility programs, implemented ISO 14001:2004 in most production facilities, and reduced waste water treatment plant sludge by 70% using filterpress technology.
Company: PT Kalbe Farma Tbk
Sector: Health Care
Country: Indonesia
Year: 2013
Type: AR2
Pages: 406
Back to company
PT Kalbe Farma Tbk
Annual Report
The report highlights PT Kalbe Farma Tbk.'s financial and operational performance for the fiscal year 2013, showcasing a 17.3% sales growth and a 10.7% increase in net profit. Key achievements include the completion of a new oncology production facility, the expansion of the Kalbe e-Store to 35 cities, and the licensing of the first stem cell laboratory in Indonesia. In terms of sustainability, the company engaged over 4,200 employee volunteers in corporate social responsibility programs, implemented ISO 14001:2004 in most production facilities, and reduced waste water treatment plant sludge by 70% using filterpress technology.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Jan 1, 2013 - Dec 31, 2013
Fiscal Year
2013
Type
Annual Report with Sustainability Disclosures
Language
English, Indonesian
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees